BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2000

View Archived Issues

Phase II/III data, including subgroup analyses, on LJP-394 discussed at ACR meeting

Read More

Company Profile: BioMarin

Read More

Caspase inhibition offers new strategy for cardiomyopathy therapy

Read More

Company Profile: Tamarkin

Read More

Schering AG and Population Council establish MENT collaboration

Read More

Suntory and Chugai to codevelop rhPTH(1-34) for osteoporosis

Read More

Sildenafil tested in patients with LVD

Read More

Niaspan proves safe and effective in diabetics

Read More

Adenosine A1 and A3 receptor agonists protect the heart against ischemia

Read More

Novel strategy for selective myoblast proliferation explored

Read More

MS-325-enhanced MRI images visualize vessel wall inflammation and plaque burden

Read More

Epix Medical reports direct clot detection with novel MRI contrast agent

Read More

Onyvax raises funds to further its cancer vaccine programs

Read More

PDL demonstrates activity at low doses, safety of HuZAF in humans; plans trials in Crohn's disease

Read More

Preclinical profile of new Onyx-Bayer Ras pathway inhibitor described in detail at NCI-EORTC-AACR

Read More

First potent and selective MMP-13 inhibitor discovered using structure-based design

Read More

NPS-1407: a potent, orally active NMDA antagonist with neuroprotective, anticonvulsant properties

Read More

Preclinical evidence points to utility of FR-167653 in organ transplantation

Read More

Avigen and Bayer collaborate to bring Coagulin-B to market

Read More

Bradykinin antagonists and their use in the treatment of pain claimed in recent patent

Read More

New Na+/H+ exchange inhibitor protects against lung I/R injury in canine model

Read More

U.S. university researchers synthesize new heregulin antagonists based on rifamycin structure

Read More

Anticancer platinum complexes designed at Unitech

Read More

Novo Nordisk presents new series of PPAR-activating compounds for diabetes and obesity

Read More

New erythromycin-based antimicrobial agents identified at Pliva

Read More

Selective delta opioid receptor agonists in the SB pipeline

Read More

Merck's new integrin receptor antagonists for thrombosis, osteoporosis, atherosclerosis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing